3CLpro inhibitor 6e

Potential 3C-like protease inhibitor.

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Antiviral

Drug status

Experimental

1
Supporting references
0
Contradictory references
0
AI-suggested references
0
Clinical trials

General information

In vitro screening of newly synthetized dipeptidyl 3C-like protease inhibitors using enzyme assay, cell lines and cultured primary human airway epithelial cells from COVID-19 patients.


Synonyms

3C-like protease inhibitor 6e

 


Supporting references

Link Tested on Impact factor Notes Publication date
3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice
in vitro enzyme assay; Huh-7 cells; VERO E6 cells; patient cultured primary airway epithelial cells 16.30

In vitro screening of newly synthetized dipeptidyl 3C-like protease inhibitors using enzyme assay, cell lines and cultured primary human airway epithelial cells from COVID-19 patients.

Aug/03/2020